These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 18617871

  • 1. Evaluation of quality of life after intratympanic streptomycin injection in patients with Ménière's disease.
    Jung J, Chun J, Kim N, Kim Y, Lee WS.
    Otol Neurotol; 2008 Sep; 29(6):816-23. PubMed ID: 18617871
    [Abstract] [Full Text] [Related]

  • 2. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C, Franco-Vidal V, Bebear JP, Darrouzet V.
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [Abstract] [Full Text] [Related]

  • 3. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V, Carner M, Colletti L.
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [Abstract] [Full Text] [Related]

  • 4. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.
    Shea PF, Richey PA, Wan JY, Stevens SR.
    Laryngoscope; 2012 Jan; 122(1):204-11. PubMed ID: 22183636
    [Abstract] [Full Text] [Related]

  • 5. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 6. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 7. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA, Chen DA, Arriaga MA.
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [Abstract] [Full Text] [Related]

  • 8. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK, Sandooram D, Prinsley PR.
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [Abstract] [Full Text] [Related]

  • 9. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 10. Quality-of-life assessment of Ménière's disease patients after surgical labyrinthectomy.
    Diaz RC, LaRouere MJ, Bojrab DI, Zappia JJ, Sargent EW, Shaia WT.
    Otol Neurotol; 2007 Jan; 28(1):74-86. PubMed ID: 16985479
    [Abstract] [Full Text] [Related]

  • 11. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E, Aidonis I, Sismanis A.
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [Abstract] [Full Text] [Related]

  • 12. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA.
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [Abstract] [Full Text] [Related]

  • 13. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 14. Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventory.
    Banerjee AS, Johnson IJ.
    J Laryngol Otol; 2006 Oct; 120(10):827-31. PubMed ID: 16707038
    [Abstract] [Full Text] [Related]

  • 15. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 16. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF.
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [Abstract] [Full Text] [Related]

  • 17. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N.
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [Abstract] [Full Text] [Related]

  • 18. Intratympanic steroid perfusion for the treatment of Ménière's disease: a retrospective study.
    Dodson KM, Woodson E, Sismanis A.
    Ear Nose Throat J; 2004 Jun; 83(6):394-8. PubMed ID: 15266874
    [Abstract] [Full Text] [Related]

  • 19. Intratympanic steroid injections for intractable Ménière's disease.
    Barrs DM, Keyser JS, Stallworth C, McElveen JT.
    Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
    [Abstract] [Full Text] [Related]

  • 20. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L, Stokroos R, Kingma H.
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.